share_log

Comparing United Health Products (OTCMKTS:UEEC) & Cadre (NYSE:CDRE)

Defense World ·  Jan 22, 2023 02:01

Cadre (NYSE:CDRE – Get Rating) and United Health Products (OTCMKTS:UEEC – Get Rating) are both small-cap industrial products companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.

Insider and Institutional Ownership

34.1% of Cadre shares are held by institutional investors. 52.9% of Cadre shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Get Cadre alerts:

Analyst Recommendations

This is a summary of current ratings for Cadre and United Health Products, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cadre 0 0 4 0 3.00
United Health Products 0 0 0 0 N/A
Cadre presently has a consensus target price of $32.80, suggesting a potential upside of 48.96%. Given Cadre's higher probable upside, equities research analysts plainly believe Cadre is more favorable than United Health Products.

Profitability

This table compares Cadre and United Health Products' net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cadre 0.80% 3.86% 1.36%
United Health Products N/A N/A -1,621.87%

Valuation and Earnings

This table compares Cadre and United Health Products' revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cadre $427.29 million 1.92 $12.66 million $0.08 275.28
United Health Products N/A N/A -$30.55 million ($0.01) -24.86

Cadre has higher revenue and earnings than United Health Products. United Health Products is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Cadre has a beta of 1.64, indicating that its stock price is 64% more volatile than the S&P 500. Comparatively, United Health Products has a beta of -0.34, indicating that its stock price is 134% less volatile than the S&P 500.

Summary

Cadre beats United Health Products on 12 of the 12 factors compared between the two stocks.

About Cadre

(Get Rating)

Cadre Holdings, Inc. manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, and various foreign government agencies. The company was founded in 1964 and is headquartered in Jacksonville, Florida.

About United Health Products

(Get Rating)

United Health Products, Inc. engages in the development, manufacture, and marketing of wound care products based on its proprietary hemostatic gauze technology. The company offers HemoStyp, which derives from all natural, regenerated oxidized cellulose and designed to absorb exudate and drainage from superficial wounds and help control bleeding. Its customers include hospitals, clinics and physicians, home care providers, municipalities and government agencies and nursing homes and assisted living environments. The company was founded on February 28, 1997 and is headquartered in Henderson, NV.

Receive News & Ratings for Cadre Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadre and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment